NASDAQ:VANI Vivani Medical (VANI) Stock Price, News & Analysis $1.26 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$1.26 +0.00 (+0.40%) As of 07:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Vivani Medical Stock (NASDAQ:VANI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Vivani Medical alerts:Sign Up Key Stats Today's Range$1.23▼$1.3550-Day Range$1.10▼$1.3952-Week Range$0.92▼$1.92Volume1.33 million shsAverage Volume202,797 shsMarket Capitalization$108.66 millionP/E RatioN/ADividend YieldN/APrice Target$3.75Consensus RatingHold Company Overview Vivani Medical Solutions, Inc. (NASDAQ: VANI) is a medical technology company focused on the design, development and commercialization of advanced specimen retrieval and hemostasis products for minimally invasive diagnostic procedures. Its core mission is to enhance procedural safety and streamline clinical workflows for interventional radiologists and pathology laboratories. The company’s flagship offerings include the StopBleed Retrieval Device and StopBleed Pad, which integrate proprietary hemostatic materials to control bleeding at biopsy sites and preserve tissue integrity. These products aim to reduce complications associated with percutaneous biopsies while facilitating efficient sample collection and handling, helping clinicians deliver faster and more accurate diagnoses. Vivani Medical serves a broad customer base that encompasses hospitals, outpatient imaging centers and pathology service providers across the United States. In addition to its direct‐sales model, the company has established distribution partnerships to extend its reach into select European and Latin American markets, supporting growing international adoption of its technologies. Founded in 2016 and headquartered in the United States, Vivani Medical became a publicly traded company in mid-2021, listing its common stock on the Nasdaq Capital Market under the ticker symbol “VANI.” The company’s leadership team brings together experienced professionals in medical device innovation, regulatory affairs and commercial operations, driving ongoing efforts to expand its product pipeline and reinforce its position in the interventional radiology market.AI Generated. May Contain Errors. Read More Vivani Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreVANI MarketRank™: Vivani Medical scored higher than 64% of companies evaluated by MarketBeat, and ranked 263rd out of 850 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingVivani Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialVivani Medical has a consensus price target of $3.75, representing about 197.6% upside from its current price of $1.26.Amount of Analyst CoverageVivani Medical has only been the subject of 2 research reports in the past 90 days.Read more about Vivani Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Vivani Medical is -3.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vivani Medical is -3.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVivani Medical has a P/B Ratio of 6.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Vivani Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.94% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 2.61, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vivani Medical has recently increased by 12.85%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVivani Medical does not currently pay a dividend.Dividend GrowthVivani Medical does not have a long track record of dividend growth. News and Social Media1.9 / 5News Sentiment0.07 News SentimentVivani Medical has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Vivani Medical this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for VANI on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Company Ownership3.7 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $5,999,998.00 in company stock, which represents 5.5217% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Vivani Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,999,998.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders53.30% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions6.78% of the stock of Vivani Medical is held by institutions.Read more about Vivani Medical's insider trading history. Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VANI Stock News HeadlinesVivani strikes reverse-merger agreement with ClearOne for BCI businessJuly 3 at 5:26 PM | finance.yahoo.comClearOne to Merge With Vivani Medical Subsidiary CortigentJuly 2, 2026 | marketwatch.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.July 6 at 1:00 AM | Banyan Hill Publishing (Ad)ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani MedicalJuly 2, 2026 | businesswire.comVivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.July 2, 2026 | globenewswire.comVivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean BakerJune 26, 2026 | globenewswire.comVivani Medical Receives Bellberry Approval to Initiate Phase 1 SLIM-1 Trial of NPM-139 Semaglutide ImplantJune 25, 2026 | quiverquant.comQVivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,587,301 SharesJune 17, 2026 | insidertrades.comSee More Headlines VANI Stock Analysis - Frequently Asked Questions How have VANI shares performed this year? Vivani Medical's stock was trading at $1.23 at the beginning of 2026. Since then, VANI shares have increased by 2.4% and is now trading at $1.26. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) released its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.08) EPS for the quarter, meeting analysts' consensus estimates of ($0.08). When did Vivani Medical IPO? Vivani Medical (VANI) raised $32 million in an IPO on Tuesday, November 18th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vivani Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vivani Medical investors own include Enterprise Products Partners (EPD), Altimmune (ALT), Caribou Biosciences (CRBU) and Enbridge (ENB). Company Calendar Last Earnings5/13/2026Today7/06/2026Next Earnings (Estimated)8/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 VANI's financial health is in the Yellow zone, according to TradeSmith. VANI has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:VANI CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees20Year FoundedN/APrice Target and Rating Average Price Target for Vivani Medical$3.75 High Price Target$4.00 Low Price Target$3.50 Potential Upside/Downside+197.6%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$26.61 million Net MarginsN/A Pretax MarginN/A Return on Equity-264.04% Return on Assets-79.85% Debt Debt-to-Equity RatioN/A Current Ratio3.18 Quick Ratio3.18 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.20 per share Price / Book6.30Miscellaneous Outstanding Shares86,240,000Free Float40,272,000Market Cap$108.66 million OptionableOptionable Beta2.33 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:VANI) was last updated on 7/6/2026 by MarketBeat.com Staff. From Our PartnersThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon Musk on His New Invention: “An Infinite Money Glitch.”Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's ...Brownstone Research | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredBuy the “unseen winner of the AI race” before July 22Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split...Chaikin Analytics | SponsoredThey proved it worked in '76. Then buried it.In 1976, Chevron, Unocal, and Texaco each confirmed the same energy technology worked - no fuel costs, no carb...Behind the Markets | SponsoredThe Warsh Fed and what it could mean for your savingsThe Fed just changed hands, and Reagan Gold Group says there may be a short window before the impact shows up ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
